Alliance Pharma Plc (APH) Ordinary 1p
Share news, reports & tips
27 November 2019 15:00
(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and...
17 July 2019 08:30
(Sharecast News) - Healthcare group Alliance Pharma saw its revenues improve over the first half of its trading year with sustained growth across its product portfolio driven by the firm's continued...
23 May 2019 10:52
(Sharecast News) - The Competition and Markets Authority (CMA) has accused four pharmaceutical firms of deliberately restricting the supply of an anti-nausea prescription drug, causing annual NHS costs for...
10 April 2019 16:05
(Sharecast News) - Alliance Pharma announced on Wednesday that 'Xonvea' has gained marketing approval in the Republic of Ireland from the country's medicines regulator, the Health Products...
26 March 2019 11:38
(Sharecast News) - Alliance Pharma's shares climbed on Tuesday as annual revenues climbed after its performance was boosted by acquisitions and international business, with overseas sales overtaking...
21 January 2019 12:42
(Sharecast News) - Alliance Pharma on Monday reported a jump in revenue after a strong performance from its 'star' products and newly acquired Nizoral brand.
2 October 2018 09:56
(Sharecast News) - Alliance Pharma launched its prescription product for the treatment of nausea and vomiting of pregnancy across the UK on Tuesday.
19 September 2018 09:28
(Sharecast News) - As Alliance Pharma's overseas transformation continued throughout the first half of its trading year, the AIM-listed group managed to record some growth in both revenues and profits.
25 July 2018 08:24
(Sharecast News) - Specialty pharmaceutical group Alliance Pharma said on Wednesday that it was on track to meet expectations after "strong" performances from its MacuShield, Vamousse and Kelo-Cote...
6 July 2018 09:04
(Sharecast News) - Alliance Pharma on Friday received approval from the medicines and healthcare products regulatory agency for a UK marketing authorisation application for the company's morning...
19 June 2018 10:36
(Sharecast News) - Speciality pharmaceutical company Alliance Pharma has agreed to acquire exclusive marketing rights to medical anti-dandruff shampoo brand Nizoral in the Asia-Pacific region from Johnson...
7 June 2018 13:28
(Sharecast News) - Alliance Pharma: Numis downgrades to add with a target price of 99p.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2019. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.